The present invention provides compounds useful in inhibiting protein kinase B (PKB/Akt). Compositions comprising such compounds and their use are also provided.
Isolation of the trimer of compound 48/80 and determination of its histamine-releasing activity.
The trimer of compound 48/80 was isolated and its potency for histamine release from rat peritoneal mast cells was examined. ED50 (the concentration giving 50% histamine release) of the trimer was 2×10-5M. The result indicated that the trimer is not as inactive as was previously considered.